Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

PHCY310 Integrated Modules B

Due to COVID-19 restrictions, a selection of on-campus papers will be made available via distance and online learning for eligible students.
Find out which papers are available and how to apply on our COVID-19 website

Integrated pharmaceutical and biomedical sciences, clinical pharmacology, therapeutics, and professional practice for patient-oriented care and population health in respiratory, cardiovascular, renal disorders and endocrinology.

Paper title Integrated Modules B
Paper code PHCY310
Subject Pharmacy
EFTS 0.5
Points 60 points
Teaching period Semester 1 (On campus)
Domestic Tuition Fees (NZD) $4,209.00
International Tuition Fees (NZD) $21,344.00

^ Top of page

Limited to
BPharm
Contact

Hesham Al-Sallami

Teaching staff

Paper Co-ordinator: Hesham Al-Sallami

Paper Structure

Lectures, Workshops, Skills Workshops, Marae visit, Placement

Textbooks

Textbooks are available through the library

Course outline

This paper is divided into three parts:

  1. Introduction to the therapeutic systems (respiratory, cardiovascular, renal endocrine).
  2. Building integration of the systems.
  3. Integration of systems for patient-centred care.

Each part will use context from respiratory, cardiovascular, renal and endocrine systems. Therapeutic areas that will be covered across the three parts, include: common upper respiratory tract infections, respiratory allergic diseases, cystic fibrosis, asthma, hypertension, non-insulin dependent diabetes mellitus, chronic kidney disease, hyperlipidaemia, acute coronary syndromes and myocardial infarction, pulmonary embolism, insulin dependent diabetes mellitus, dysrhythmias, acute kidney injury, chronic obstructive pulmonary disease, heart failure, thyroid disorders, cortisol disorders, end stage renal disease, rheumatic fever, pulmonary fibrosis.

Graduate Attributes Emphasised

Global perspective, Interdisciplinary perspective, Lifelong learning, Scholarship
View more information about Otago's graduate attributes.

Learning Outcomes

^ Top of page

Timetable

Semester 1

Location
Dunedin
Teaching method
This paper is taught On Campus
Learning management system
Blackboard

Lecture

Stream Days Times Weeks
Attend
A1 Monday 12:00-12:50 19
Monday 13:00-13:50 11, 15, 18
Monday 14:00-15:50 9
Tuesday 08:00-08:50 12
AND
C1 Wednesday 09:00-09:50 9-11, 15-16, 19-21
Wednesday 10:00-11:50 15, 18-19
Wednesday 11:00-11:50 10, 13, 16, 20-21
Wednesday 13:00-13:50 10, 16-17, 19
Wednesday 14:00-14:50 16-17
Wednesday 14:00-15:50 13, 15, 18
Wednesday 15:00-15:50 16, 19
Wednesday 16:00-16:50 10, 19
AND
D1 Thursday 09:00-09:50 12
Thursday 10:00-10:50 12
Thursday 11:00-11:50 12
AND
E1 Wednesday 16:00-16:50 15
Friday 09:00-09:50 11
Friday 09:00-11:50 9
Friday 10:00-10:50 11, 15
Friday 14:00-14:50 11
Friday 15:00-16:50 9

Integrated pharmaceutical and biomedical sciences, clinical pharmacology, therapeutics, and professional practice for patient-oriented care and population health in respiratory, cardiovascular, renal disorders and endocrinology.

Paper title Integrated Modules B
Paper code PHCY310
Subject Pharmacy
EFTS 0.5
Points 60 points
Teaching period Semester 1 (On campus)
Domestic Tuition Fees Tuition Fees for 2022 have not yet been set
International Tuition Fees Tuition Fees for international students are elsewhere on this website.

^ Top of page

Limited to
BPharm
Contact

hesham.al-sallami@otago.ac.nz

Teaching staff

Paper Co-ordinator: Hesham Al-Sallami

Paper Structure

This paper is divided into three parts:

  1. Introduction to the therapeutic systems (respiratory, cardiovascular, renal, endocrine)
  2. Building integration of the systems
  3. Integration of systems for patient-centred care

Each part will use context from respiratory, cardiovascular, renal and endocrine systems. Therapeutic areas that will be covered across the three parts, include: common upper respiratory tract infections, respiratory allergic diseases, cystic fibrosis, asthma, hypertension, non-insulin dependent diabetes mellitus, chronic kidney disease, hyperlipidaemia, acute coronary syndromes and myocardial infarction, pulmonary embolism, insulin dependent diabetes mellitus, dysrhythmias, acute kidney injury, chronic obstructive pulmonary disease, heart failure, thyroid disorders, cortisol disorders, end stage renal disease, rheumatic fever, pulmonary fibrosis.

Teaching Arrangements
  • Lectures
  • Workshops
  • Skills Workshops
  • Marae visit
  • Placement
Textbooks

Textbooks are available through the library.

Graduate Attributes Emphasised

Global perspective, Interdisciplinary perspective, Lifelong learning, Scholarship
View more information about Otago's graduate attributes.

Learning Outcomes

Students who successfully complete the paper will:

  • Show awareness of and modifies their own communication response based on feedback
  • Recognise when communication is unsuccessful and adopt appropriate strategies for dealing with it
  • Communicate clinical information and expert scientific knowledge effectively to different audiences
  • Use communication technology effectively
  • Create an environment that is appropriate for consultations
  • Reflect on how social/cultural factors related to oneself and others impact on communication
  • Pronounce te reo Māori correctly; understand common and relevant words and use them appropriately
  • Understand the process of pharmaceutical development
  • Interpret and predicts how the physical and chemical properties of a drug may influence drug effects and pharmacokinetics
  • Understand the pharmacological actions and metabolic fate associated with drug molecules
  • Describe the aetiology, pathophysiology, signs and symptoms, risk factors, diagnostic methods, and complications of selected human diseases
  • Apply the principles of drug pharmacodynamics to understand the actions, drug-drug interactions and side effects of medicines
  • Apply knowledge of pharmaceutical sciences for patient care
  • Evaluate and recommend the suitability of a drug, dosage form, dose and / or route of administration with respect to therapeutic efficacy
  • Consult people to collect demographic, medicine, clinical histories and the person's aspirations appropriately to assess and decide on a treatment plan
  • Document activities clearly, concisely, and accurately using appropriate medical terminology
  • Elicit the personal goals of people / whānau and the practical realities of their lives for their care
  • Describe, integrate, and apply the principles of physiology, pathology, microbiology, pharmacoepidemiology and pharmacotherapy to optimise patient care
  • Apply knowledge of pharmacokinetics-pharmacodynamics to the time-course of drug effects in order to optimise person outcomes
  • Determine and account for variability in response and factors that affect an individual's response and dose requirements
  • Develop, implement, and evaluate a person-centred care plan and communicate this care plan appropriately and undertake appropriate evaluation of outcomes
  • Identify views and concerns of people / whānau and incorporates these into a care plan
  • Recognise issues in health literacy and help people / whānau to understand their health
  • Communicate the care plan with an individual, understands the person's perceptions and assist them to understand their treatment(s)
  • Identify, discuss and work with people to increase adherence to treatment that may include lifestyle / health-behaviour change
  • Monitor and evaluate medication effects with individuals to improve outcomes from therapy
  • Synthesise and integrate information to formulate differential diagnoses, triage and treat with non-prescription medicines common ailments
  • Monitor and evaluate medication effects with individuals to improve outcomes from therapy
  • Recognise when to refer people to another healthcare professional
  • Describe and apply the principles of evidence-based pharmacy practice
  • Recognise and describe the wider societal factors that contribute to health inequities to promote and optimise health outcomes
  • Identify disparities between the health status of different groups in New Zealand including Māori and non- Māori and discusses factors contributing to these inequalities
  • Describe factors that contribute to ethnic differences in health outcomes, including for Māori and Pacific
  • Identify targeted interventions and describe ways in which they address determinants of health and improve health outcomes for Māori and non- Māori
  • Describe rongoā Māori, the roles of rongoā providers in the community, and how and why people use rongoā
  • Explain how Māori and other cultures and cultural practices affect health-related behaviour and interactions with the health system
  • Recognise and describe aspects of people' experiences of the healthcare system and the impact of illness on people, carers and whānau
  • Describe how people move through different aspects of the health system and access health services
  • Recognise, explain and demonstrates ethical principles and values underpinning the profession
  • Maintain an individual's rights to confidentiality and privacy
  • Demonstrate professional integrity through appropriate professional behaviour
  • Recognise, explain and comply with legislation and other regulations that are relevant to pharmacy
  • Dispense medicines in accordance with legal requirements, professional responsibilities and safety of the person

^ Top of page

Timetable

Semester 1

Location
Dunedin
Teaching method
This paper is taught On Campus
Learning management system
Blackboard

Lecture

Stream Days Times Weeks
Attend
A1 Monday 09:00-10:50 9
Monday 12:00-12:50 12
Monday 13:00-14:50 9
AND
C1 Wednesday 08:00-08:50 14
Wednesday 08:00-09:50 15
Wednesday 09:00-09:50 9-14, 17-20
Wednesday 11:00-11:50 9-14, 17-20
Wednesday 13:00-13:50 9-12, 14-15, 17-18, 20
Wednesday 14:00-14:50 9-15, 17-19
Wednesday 15:00-15:50 9-15, 17-19
AND
D1 Thursday 08:00-08:50 11
AND
E1 Friday 09:00-09:50 11-12
Friday 10:00-10:50 11-12
Friday 14:00-14:50 12
Friday 15:00-15:50 12